Assessing Spinal Pain With an Artificial Intelligence-assisted Whole Body Electrical Stimulation Device
Validity of an AI-Supported Whole-Body Electrical Stimulation Device for Spinal Pain Assessment: A Comparison With Self-Reported Pain Scores
1 other identifier
observational
200
1 country
1
Brief Summary
The goal of this observational study is to investigate the correlation between self-reported pain and the measurements obtained using an artificial intelligence-assisted whole-body electrical stimulation device (StimaWELL 120MTRS system) in individuals with chronic back pain. The main question it aims to answer is: Is there any correlation between the pain intensity assessed with StimaWELL 120MTRS system, dolorimeter and self-report in adults with chronic back pain? The patients who have back pain for the duration longer than 3 months and have been eximaned by a medical doctor will be assessed with StimaWELL 120MTRS system, dolorimeter, and will be asked to rate their pain intensity in Numerical Pain Rating Scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 15, 2025
CompletedStudy Start
First participant enrolled
November 15, 2025
CompletedFirst Posted
Study publicly available on registry
November 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2026
CompletedDecember 18, 2025
December 1, 2025
4 months
August 15, 2025
December 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pain intensity measured by the StimaWELL 120MTRS system
The StimaWELL® EMS device is a high-tech modulated low-frequency, 12-channel, mid-frequency stimulation device. The output of the calibration process will be recorded as data to use in the analysis.
baseline, one time
Pressure pain threshold
PPT will be assessed using a dolorimeter at four bilateral points (upper trapezius, lower trapezius, 5 cm lateral to L3 spinous process, and 2 cm cranial to the posterior superior iliac spine).
baseline, pre-procedure
Patient-reported pain
Participants will be asked to indicate the location of their back pain experienced over the last week on a body diagram, which shows the regions where the electrodes will be placed in a faint outline. For each marked region, participants will be asked to rate their pain intensity using the Numerical Pain Rating Scale. The scale ranges from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Higher scores represent greater pain intensity.
baseline, pre-procedure
Study Arms (1)
Patients with chronic back pain
Eligibility Criteria
Participants will be recruited from the eligible and volunteer patients who will visit the healthy living center in study duration.
You may qualify if:
- Experiencing back pain for more than three months
- Experiencing recurrent back pain over the last week
- Not having used analgesic or muscle relaxant medications in the last week
- Aged between 18 and 60 years
- Diagnosed with chronic low back pain by a medical doctor
- Literate and able to cooperate with study procedures
- Willing to participate in the study
You may not qualify if:
- Having neurological, inflammatory, radiculopathy, vertebral fracture, or similar conditions
- Experiencing acute-onset pain
- Being pregnant or at risk of pregnancy
- Having a psychiatric diagnosis and currently taking medication
- Having a skin disease or lesion in the area where electrodes will be applied
- Currently undergoing physical therapy
- Having vestibular, auditory, or cognitive impairments
- Possessing an electronic implant
- Having a cardiac arrhythmia
- Having a coronary or carotid stent
- Being diagnosed with epilepsy
- Having severe osteoporosis of the spine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AMASYAŞAM Sağlıklı Yaşam Merkezi
Amasya, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 15, 2025
First Posted
November 24, 2025
Study Start
November 15, 2025
Primary Completion
March 15, 2026
Study Completion
March 15, 2026
Last Updated
December 18, 2025
Record last verified: 2025-12